Aegerion Pharmaceuticals (AEGR)

Add to Watchlists
Create an Alert
43.43 -0.09  -0.21% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
AEGR Price Chart
View All Events

AEGR Events

Date Type Description
Feb 26 Misc Aegerion Pharmaceuticals, Inc. Earnings Conference Call
Feb 26 Earnings Aegerion Pharmaceuticals, Inc. Earnings Results. Estimate: -0.28.
Jan 09 Misc Aegerion Pharmaceuticals Reports Preliminary 2013 Net Product Sales, Its Outlook for 2014 and Other Business Updates
Nov 07 Misc Aegerion Pharmaceuticals to Host Analyst and Investor Day on Thursday, November 7
Oct 30 Earnings Aegerion Pharmaceuticals to Announce Third-quarter 2013 Financial Results on Wednesday, October 30. Estimate: -0.49.
Jul 30 Misc Q2 2013 Earnings Conference Call
Jul 30 Earnings Aegerion Pharmaceuticals to Announce Second-quarter 2013 Financial Results on Tuesday, July 30. Estimate: -0.62.
Apr 30 Misc Q1 2013 Earnings Conference Call
Apr 30 Earnings Aegerion Pharmaceuticals to Announce First Quarter 2013 Financial Results on Tuesday, April 30. Estimate: -0.71.
View All Performance Charts

AEGR Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Aegerion Pharmaceuticals is up 11.30% over the last year vs S&P 500 Total Return up 23.54%, Isis Pharmaceuticals up 77.32%, and Biogen Idec up 42.37%.

Get Quote for

PDF Report for AEGR

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download AEGR Pro Report PDF
Advertisement

Portfolio Strategies Featuring AEGR

Did Aegerion Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

AEGR Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company currently operates in one business segment focusing on the development and commercialization of its product, lomitapide.

Recent Quotes

Symbol Price Chg Chg % Market Cap
AEGR 43.43 -0.09 -0.21% 1.277B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.